Inventor · disambiguated record
Cecilia Giovanna Silvia Cotta-Ramusino
Also filed as: COTTA-RAMUSINO CECILIA · COTTA-RAMUSINO CECILIA GIOVANNA SILVIA
16 granted patents·25 pending applications·33 citations·filing 2015–2025
91Inventor score
Top patents by PatentIndex Score
41 records- 0195US12157898B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Dec 3, 2024·4 cites·17 claims
- 0295US12123034B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Oct 22, 2024·4 cites·26 claims
- 0395US12037617B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jul 16, 2024·4 cites·26 claims
- 0495US12031162B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jul 9, 2024·4 cites·26 claims
- 0595US12024728B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Jul 2, 2024·4 cites·26 claims
- 0693US12454706B2Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Granted Oct 28, 2025·1 cites·22 claims
- 0792US12270029B2CFTR-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Apr 8, 2025·3 cites·15 claims
- 0890US12201699B2Compositions and methods for promoting homology directed repairEDITAS MEDICINE INC·Filed 2021·Granted Jan 21, 2025·1 cites·17 claims
- 0990US11236313B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2017·Granted Feb 1, 2022·4 cites·14 claims
- 1087US12505549B1Microscopy image analyses for disease modelingINSITRO INC·Filed 2025·Granted Dec 23, 2025·1 cites·21 claims
- 1185US2025340907A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 1285US2025346927A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 1385US2024247243A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Application pending·0 cites
- 1484US2025288698A1Compositions and methods for promoting homology directed repairEDITAS MEDICINE INC·Filed 2024·Application pending·0 cites
- 1583US12359223B2Systems and methods for modulating chromosomal rearrangementsEDITAS MEDICINE INC·Filed 2019·Granted Jul 15, 2025·2 cites·18 claims
- 1679US2023272430A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1775US11680268B2Methods for improving CRISPR/Cas-mediated genome-editingEDITAS MEDICINE INC·Filed 2015·Granted Jun 20, 2023·1 cites·17 claims
- 1874US2023365980A1Methods for improving crispr/cas-mediated genome-editingEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1973US12049651B2Cas9 fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2021·Granted Jul 30, 2024·0 cites·18 claims
- 2072US2024132877A1Genome editing systems comprising repair-modulating enzyme molecules and methods of their useEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 2172US2024167059A1Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sitesEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 2271US2023340456A1Use of exonucleases to improve crispr/cas-mediated genome editingEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 2367US2024252682A1Hbb-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Application pending·0 cites
- 2466US2023018543A1Crispr/cas-mediated gene conversionEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 2565US2024084334A1Serpina-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 2664US2025312376A1Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cellsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 2763US2023348939A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2862US2023242899A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 2962US2024374759A1Methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3062US2023235358A1Host defense suppressing methods and compositions for modulating a genomeFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3162US2025179482A1Cftr-modulating compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 3261US2024263153A1Integrase compositions and methodsFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3360US2023131847A1Recombinase compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 3458US11866726B2Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sitesEDITAS MEDICINE INC·Filed 2018·Granted Jan 9, 2024·0 cites·12 claims
- 3557US2021366577A1Predicting disease outcomes using machine learned modelsINSITRO INC·Filed 2021·Application pending·0 cites
- 3657US2018250424A1Compositions and methods for promoting homology directed repairEDITAS MEDICINE INC·Filed 2015·Application pending·0 cites
- 3755US11667911B2Use of exonucleases to improve CRISPR/CAS-mediated genome editingEDITAS MEDICINE INC·Filed 2016·Granted Jun 6, 2023·0 cites·25 claims
- 3855US11597924B2Genome editing systems comprising repair-modulating enzyme molecules and methods of their useEDITAS MEDICINE INC·Filed 2017·Granted Mar 7, 2023·0 cites·19 claims
- 3950US2016281111A1Crispr/cas-mediated gene conversionEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 4041US2020263206A1Targeted integration systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2018·Application pending·0 cites
- 4137US2019062734A1Grna fusion molecules, gene editing systems, and methods of use thereofEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →